Renaissance Technologies Reports $73.42 Billion Portfolio in Q3 2026 13F Filing
Renaissance Technologies has disclosed its latest 13F filing for the third quarter of 2026, revealing a total portfolio value of approximately $73.42 billion as of September 30, 2026. The filing provides insight into the quantitative fund's strategic positioning and asset allocation heading into the final quarter of the year. The fund's largest holdings are concentrated in the semiconductor and biotechnology sectors, with significant positions held in Micron Technology (MU), Advanced Micro Devices (AMD), and United Therapeutics (UTHR). These allocations reflect a continued focus on high-growth technology and specialized healthcare industries.
